Greene Barry E

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 75% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Greene Barry E's trades of SAGE Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
384.86
Quantity 69,804 -23.8%
Value US$4,619,365
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-15 2022-11-10
B Purchase
69,804 -23.8%
384.86
US$4,619,365 		69,804 -23.8% 384.86 US$4,619,365
2021-08-09 2021-08-05
B Purchase
37,786 +44.7%
456.66
US$3,645,754 		37,786 +44.7% 456.66 US$3,645,754
2021-06-17 2021-06-16
B Purchase
96,415 -17.8%
59.06
US$364,634 		96,415 -17.8% 59.06 US$364,634
2020-09-11 2020-09-09
PlS Planned sale
3,346 -4.5%
124.38
US$416,175 		3,346 -4.5% 124.38 US$416,175
2020-09-11 2020-09-09
PlS Planned sale
27,109 -26.9%
123.39
US$3,344,980 		27,109 -26.9% 123.39 US$3,344,980
2020-09-11 2020-09-09
PlS Planned sale
14,075 -12.3%
122.66
US$1,726,440 		14,075 -12.3% 122.66 US$1,726,440
2020-07-09 2020-07-07
PlS Planned sale
22,265 -26.3%
159.99
US$3,562,177 		22,265 -26.3% 159.99 US$3,562,177
2020-05-07 2020-05-06
PlS Planned sale
22,265 -26.3%
149.99
US$3,339,527 		22,265 -26.3% 149.99 US$3,339,527
2019-10-24 2019-10-22
PlS Planned sale
58,913 -52.7%
89.99
US$5,301,581 		58,913 -52.7% 89.99 US$5,301,581